Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020.

Republic of Korea SARS-CoV-2 whole-genome sequencing

Journal

Osong public health and research perspectives
ISSN: 2210-9099
Titre abrégé: Osong Public Health Res Perspect
Pays: Korea (South)
ID NLM: 101563309

Informations de publication

Date de publication:
Feb 2021
Historique:
entrez: 4 3 2021
pubmed: 5 3 2021
medline: 5 3 2021
Statut: ppublish

Résumé

Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22

Identifiants

pubmed: 33659153
doi: 10.24171/j.phrp.2021.12.1.06
pii: ophrp-12-37
pmc: PMC7899228
doi:

Types de publication

Journal Article

Langues

eng

Pagination

37-43

Informations de copyright

©2021 Korea Disease Control and Prevention Agency.

Déclaration de conflit d'intérêts

Conflicts of Interest The authors have no conflicts of interest to declare.

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Osong Public Health Res Perspect. 2020 Feb;11(1):3-7
pubmed: 32149036
J Korean Med Sci. 2020 Feb 10;35(5):e61
pubmed: 32030925
Sci Rep. 2020 Aug 20;10(1):14031
pubmed: 32820179
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Ae Kyung Park (AK)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Il-Hwan Kim (IH)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Junyoung Kim (J)

Division of Bacterial Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Jeong-Min Kim (JM)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Heui Man Kim (HM)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Chae Young Lee (CY)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Myung-Guk Han (MG)

Division of Viral Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Gi-Eun Rhie (GE)

Division of High-Risk Pathogens, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Donghyok Kwon (D)

Division of Public Health Emergency Response Research, Bureau of Public Health Emergency Preparedness, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Jeong-Gu Nam (JG)

Division of Laboratory Diagnosis Analysis, Capital Regional Center for Disease Control and Prevention, Seoul, Korea.

Young-Joon Park (YJ)

Central Disease Control Headquarters Epidemiological Investigation Team, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Jin Gwack (J)

Central Disease Control Headquarters Epidemiological Investigation Team, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Nam-Joo Lee (NJ)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

SangHee Woo (S)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Jin Sun No (JS)

Division of High-Risk Pathogens, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Jaehee Lee (J)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Jeemin Ha (J)

Division of Laboratory Diagnosis Analysis, Chungcheong Regional Center for Disease Control and Prevention, Daejeon, Korea.

JeeEun Rhee (J)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Cheon-Kwon Yoo (CK)

Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Eun-Jin Kim (EJ)

Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Classifications MeSH